Utama › Leukemia Mieloid Akut › New Jersey › Clifton
Kajian klinikal Leukemia Mieloid Akut di Clifton, NJ
12 kajian untuk Leukemia Mieloid Akut sedang mencari peserta di lokasi dalam dan sekitar Clifton (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Mengambil pesertaFasa 1
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi jauh
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Mengambil pesertaFasa 3
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi jauh
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Mengambil pesertaFasa 3
- Hackensack University Medical Center, Hackensack · 7 mi jauh
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
Mengambil pesertaFasa 2
- John Theurer Cancer Center at Hackensack UMC, Hackensack · 7 mi jauh
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Mengambil pesertaFasa 1/2
- Hackensack University Medical Center, Hackensack · 7 mi jauh
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Mengambil pesertaFasa 3
- Hackensack University Medical Center, HMH, Hackensack · 7 mi jauh
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Mengambil pesertaFasa 1
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi jauh
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Mengambil pesertaFasa 2
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi jauh
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Mengambil pesertaKajian pemerhatian
- Hackensack University Medical Center, Hackensack · 7 mi jauh
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Mengambil pesertaFasa 2/3
- John Theurer Cancer Center / Hackensack University, Hackensack · 7 mi jauh
Phase IB/II of CPX-351 for Relapse Prevention in AML
Mengambil pesertaFasa 1/2
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi jauh
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Mengambil pesertaFasa 1
- Hackensack University Medical Center, Hackensack · 7 mi jauh
Kajian Leukemia Mieloid Akut di bandar lain
- Houston, TX85 kajian
- New York City, NY51 kajian
- Boston, MA44 kajian
- Seattle, WA41 kajian
- Baldwin Park, CA40 kajian
- Columbus, OH35 kajian
- Philadelphia, PA34 kajian
- Durham, NC33 kajian
- Atlanta, GA31 kajian
- Tampa, FL29 kajian
- Chicago, IL26 kajian
- Portland, OR25 kajian
Kajian lain di Clifton
- Kanser Paru-paru Bukan Sel Kecil24 kajian
- Kanser (semua jenis)15 kajian
- Mieloma Pelbagai14 kajian
- Kanser Metastatik12 kajian
- Kanser Payudara12 kajian
- Kanser Prostat12 kajian
- Kanser Ovari11 kajian
- Kanser Paru-paru10 kajian
- Kanser Kolorektal8 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher8 kajian
- Kanser Endometrium8 kajian
- Kegagalan Jantung8 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.